What is the Alivus Life Sciences Ltd P/E ratio?

The Alivus Life Sciences Ltd P/E ratio is 25.03x, based on its current share price and earnings per share.

What is the Alivus Life Sciences Ltd P/B ratio?

The Alivus Life Sciences Ltd price-to-book (P/B) ratio is 4.67x, based on its market price relative to its book value per share.

What is the Alivus Life Sciences Ltd ROE?

The Alivus Life Sciences Ltd return on equity (ROE) is 16.94%, which indicates how effectively the company generates profits from shareholders' equity.

What is the Alivus Life Sciences Ltd ROCE?

The Alivus Life Sciences Ltd return on capital employed (ROCE) is 22.33%, indicating how efficiently the company generates operating returns from its capital employed.

What is the Alivus Life Sciences Ltd debt-to-equity ratio?

The Alivus Life Sciences Ltd debt-to-equity ratio is 0.02x, which indicates the company's level of debt relative to shareholders' equity.

What is the Alivus Life Sciences Ltd dividend yield?

The Alivus Life Sciences Ltd dividend yield is approximately 0.39%, based on the latest dividend and current market price.

What is the Alivus Life Sciences Ltd book value?

The Alivus Life Sciences Ltd book value per share is ₹271.41, representing the net asset value attributable to each equity share.

What is the Alivus Life Sciences Ltd face value?

The Alivus Life Sciences Ltd face value is ₹2 per share.

Alivus Life Sciences Ltd Fundamentals: P/E, P/B, ROE, ROCE, EPS & More

Alivus Life Sciences Ltd Share Price

Detail Overview

Pharmaceuticals - Indian - Bulk Drugs & Formln M/SNSE

₹1,269.00

+11.10(+0.88%)

As on 22 Oct 2026 at 15:56

As of 22 Oct 2026 at 15:56, Alivus Life Sciences Ltd is trading at ₹1,269.00. The 52-week range stands at ₹819.00–₹1,493.80, with a market cap of ₹15.56 thousand crore. At a P/E of 25.03 and a dividend yield of 0.39%, it is a mid-cap stock in the Pharmaceuticals sector.

Market Cap

₹15.56K Cr

PE Ratio

25.03

ROCE

22.33%